When your social media account starts spewing out nonsensical or threatening status updates, it's safe to assume that it has ...

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...

A new randomized clinical trial investigates whether 3D total-body photography improves melanoma detection and impacts biopsy rates in high-risk patients.

Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...

But according to recent stats from Melanoma Focus, the artificial tanning devices appear to be increasing in popularity with ...

Researchers from Prof. Yardena Samuels’s lab manipulated cancer cells into making themselves visible to the immune system, creating a new approach that gives hope to patients with previously untreatab ...

The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...

Roads shut down. Music in the air. Jam in the Streets.

Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...

Melanoma cells, the most aggressive form of skin cancer, produce a protein that blocks the recognition and removal of the ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.